BIOL logo

BIOLASE, Inc. (BIOL)

Profile

Full Name

BIOLASE, Inc.

Ticker

NASDAQ: BIOL

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

November 12, 1992

Indexes

Not included

Website

https://www.biolase.com

Employees

157

Key Details

Price

$0.13

Market Cap

Last Dividend

$125.00

TTM Dividend Yield

-

Annual Revenue

$49.16M(1.45% YoY)

Annual EPS

-$29.44(92.93% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.13
    BIOL price is $0.13

    30-Day Relative Volume

    0.00
    BIOL 30-day relative volume is 0.00

    Price Performance

    Price Most Recent Change

    -
    BIOL price change on Nov 25, 2025 is unknown

    Price YTD Change

    -
    BIOL price ytd change is unknown

    Price 1-Year Change

    +2480%
    BIOL price is up +2480% year-on-year

    Price 3-Year Change

    -99.87%
    BIOL price is down -99.87% over the past 3 years

    Price Range

    Price All-Time High

    $246398.34
    BIOL price is currently -100.00% below its historical high of $246398.34

    Price 3-Year Low

    $0.00
    BIOL price is currently >+9900.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $4.72M
    BIOL market cap is $4.72 million

    Market Cap 3-Year Change

    -31.22%
    BIOL market cap is down -31.22% over the past 3 years

    Market Cap All-Time High

    $490.49M
    BIOL market cap is currently -99.04% below its historical high of $490.49 million

    Market Cap Sector Percentile

    10.5%
    BIOL market cap is higher than 10.5% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    BIOL shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +51084.76%
    BIOL shares outstanding is up +51084.76% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    193.43
    BIOL beta is 193.43

    200-day SMA

    $0.01
    BIOL price is currently +760.00% above its 200-day simple moving average

    50-day SMA

    $0.01
    BIOL price is currently +760.00% above its 50-day simple moving average

    14-Day RSI

    0.00
    BIOL 14-day relative strength index is 0.00

    Volume

    0.00
    BIOL 30-day relative volume is 0.00

    ATR

    $0.00
    BIOL average true range is $0.00

    10-day Historical Volatility

    4348.53%
    BIOL 10-day historical volatility is 4348.53%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $125.00
    BIOL last dividend was $125.00 per share, with an ex-dividend date of April 21, 2005

    Next Dividend

    -
    BIOL next dividend has not yet been announced

    Dividend per share

    Dividend Per Share

    -
    BIOL annual dividend per share value is unknown

    Dividend Per Share Sector Percentile

    -
    BIOL annual dividend per share is unknown

    Dividend Per Share 1-Year Change

    -
    BIOL annual dividend per share 1-year change is unknown

    Dividend Per Share 3-Year Change

    -
    BIOL annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend Yield

    -
    BIOL annual dividend yield value is unknown

    Dividend Yield Sector Percentile

    -
    BIOL annual dividend yield is unknown

    Other

    Payout Ratio

    0.00%
    BIOL annual payout ratio is 0.00%

    Dividends Paid

    $0.00
    BIOL annual dividends paid is $0.00

    Free Cash Flow

    -$15.40M
    BIOL annual free cash flow is -$15.40 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $49.16M
    BIOL annual revenue is $49.16 million

    Revenue Analysts Estimate

    $49.50M
    BIOL annual revenue is currently -0.68% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +1.45%
    BIOL annual revenue is up +1.45% year-on-year

    Revenue Sector Percentile

    61.28%
    BIOL annual revenue is higher than 61.28% of companies in Healthcare sector

    EPS

    EPS

    -$29.44
    BIOL annual earnings per share is -$29.44

    EPS Analysts Estimate

    -$0.31
    BIOL annual earnings per share is currently -9395.42% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +92.93%
    BIOL annual earnings per share is up +92.93% year-on-year

    EPS Sector Percentile

    7.3%
    BIOL annual earnings per share is higher than 7.3% of companies in Healthcare sector

    Profit

    Gross Profit

    $16.72M
    BIOL annual gross profit is $16.72 million

    Gross Margin

    34.02%
    BIOL annual gross profit margin is 34.02%

    Operating Profit

    -$17.94M
    BIOL annual operating income is -$17.94 million

    Operating Margin

    -36.48%
    BIOL annual operating profit margin is -36.48%

    Net Income

    -$20.63M
    BIOL annual net profit is -$20.63 million

    Net Margin

    -41.97%
    BIOL annual net profit margin is -41.97%

    Expenses

    Total Expenses

    $67.10M
    BIOL annual total expenses is $67.10 million

    Operating Expenses

    $34.66M
    BIOL annual total operating expenses is $34.66 million

    Cost Of Goods Sold

    $32.44M
    BIOL annual cost of goods sold is $32.44 million

    Selling, General & Administrative Expenses

    $28.66M
    BIOL annual SG&A is $28.66 million

    Depreciation & Amortization

    $2.80M
    BIOL annual D&A is $2.80 million

    Interest Expense

    $0.00
    BIOL annual interest expense is $0.00

    Income Tax

    $31.00K
    BIOL annual income tax is $31.00 thousand

    EBIT & EBITDA

    EBIT

    -$18.24M
    BIOL annual earnings before interest & taxes is -$18.24 million

    EBITDA

    -$15.44M
    BIOL annual EBITDA is -$15.44 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $35.10M
    BIOL annual total assets is $35.10 million

    Non Current Assets

    $10.24M
    BIOL annual long term assets is $10.24 million

    Current Assets

    $24.86M
    BIOL annual total current assets is $24.86 million

    Cash and Cash Equivalents

    $6.57M
    BIOL annual cash & cash equivalents is $6.57 million

    Accounts Receivable

    $5.48M
    BIOL annual accounts receivable is $5.48 million

    Inventory

    $11.43M
    BIOL annual inventory is $11.43 million

    Liabilities

    Total Liabilities

    $35.35M
    BIOL annual total liabilities is $35.35 million

    Long Term Liabilities

    $13.48M
    BIOL annual total long term liabilities is $13.48 million

    Current Liabilities

    $19.66M
    BIOL annual current liabilities is $19.66 million

    Accounts Payable

    $6.07M
    BIOL annual accounts payable is $6.07 million

    Debt

    Total Debt

    $17.91M
    BIOL annual total debt is $17.91 million

    Total Debt 1-Year Change

    +14.16%
    BIOL annual total debt is up +14.16% year-on-year

    Long Term Debt

    $12.55M
    BIOL annual long term debt is $12.55 million

    Short Term Debt

    $3.15M
    BIOL annual short term debt is $3.15 million

    Equity & Capital

    Shareholders Equity

    -$247.00K
    BIOL annual stockholders equity is -$247.00 thousand

    Book Value

    -$247.00K
    BIOL annual book value is -$247.00 thousand

    Retained Earnings

    -$316.80M
    BIOL annual retained earnings is -$316.80 million

    Working Capital

    $5.20M
    BIOL annual working capital is $5.20 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$14.09M
    BIOL annual cash from operations is -$14.09 million

    Cash From Operations 1-Year Change

    +47.35%
    BIOL annual cash from operations is up +47.35% year-on-year

    Cash From Investing

    -$1.13M
    BIOL annual cash from investing is -$1.13 million

    Cash From Investing 1-Year Change

    +69.71%
    BIOL annual cash from investing is up +69.71% year-on-year

    Cash From Financing

    $17.43M
    BIOL annual cash from financing is $17.43 million

    Cash From Financing 1-Year Change

    +278.75%
    BIOL annual cash from financing is up +278.75% year-on-year

    CAPEX

    CAPEX

    $1.31M
    BIOL annual capital expenditures is $1.31 million

    CAPEX 1-Year Change

    -64.82%
    BIOL annual capital expenditures is down -64.82% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$15.40M
    BIOL annual free cash flow is -$15.40 million

    Free Cash Flow 1-Year Change

    +49.48%
    BIOL annual free cash flow is up +49.48% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    34.02%
    BIOL annual gross profit margin is 34.02%

    Operating Margin

    -36.48%
    BIOL annual operating profit margin is -36.48%

    Net Margin

    -41.97%
    BIOL annual net profit margin is -41.97%

    ROA & ROE

    ROA

    -56.30%
    BIOL annual return on assets is -56.30%

    ROE

    -888.93%
    BIOL annual return on equity is -888.93%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    BIOL price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    BIOL price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -0.90
    BIOL price to book ratio is -0.90

    PB Ratio Sector Percentile

    10.9%
    BIOL price to book ratio is higher than 10.9% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.10
    BIOL price to sales ratio is 0.10

    PS Ratio Sector Percentile

    5.43%
    BIOL price to sales ratio is higher than 5.43% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $18.73M
    BIOL enterprise value is $18.73 million

    Enterprise Value Sector Percentile

    26.01%
    BIOL enterprise value is higher than 26.01% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.72
    BIOL EV/EBITDA is -1.72

    EV/EBITDA Sector Percentile

    41.02%
    BIOL EV/EBITDA is higher than 41.02% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.26
    BIOL annual current ratio is 1.26

    Quick Ratio

    0.68
    BIOL annual quick ratio is 0.68

    Leverage

    Debt To Equity

    7.18
    BIOL annual debt to equity ratio is 7.18

    Interest Coverage Ratio

    -
    BIOL annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    4
    BIOL piotroski f-score is 4

    Altman Z-Score

    -12.69
    BIOL altman z-score is -12.69

    Analyst ratings

    Recent major analysts updates

    Aug 12, 24 Benchmark
    Speculative Buy
    May 14, 24 Benchmark
    Speculative Buy
    Apr 1, 24 Ascendiant Capital
    Buy
    Mar 22, 24 Benchmark
    Speculative Buy
    May 31, 23 Lake Street
    Buy
    Mar 29, 23 Maxim Group
    Buy
    Mar 29, 23 Benchmark
    Speculative Buy
    May 20, 22 Lake Street
    Buy
    Oct 14, 20 Maxim Group
    Buy
    Jun 19, 19 Benchmark
    Speculative Buy

    Institutional Ownership

    Screeners with BIOL included

    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for BIOLASE, Inc.?
    • Does BIOLASE, Inc. pay dividends?
    • What sector is BIOLASE, Inc. in?
    • What industry is BIOLASE, Inc. in?
    • What country is BIOLASE, Inc. based in?
    • When did BIOLASE, Inc. go public?
    • Is BIOLASE, Inc. in the S&P 500?
    • Is BIOLASE, Inc. in the NASDAQ 100?
    • Is BIOLASE, Inc. in the Dow Jones?
    • When was BIOLASE, Inc.'s last earnings report?
    • When does BIOLASE, Inc. report earnings?

    What is the ticker symbol for BIOLASE, Inc.?

    The ticker symbol for BIOLASE, Inc. is NASDAQ:BIOL

    Does BIOLASE, Inc. pay dividends?

    No, BIOLASE, Inc. does not pay dividends

    What sector is BIOLASE, Inc. in?

    BIOLASE, Inc. is in the Healthcare sector

    What industry is BIOLASE, Inc. in?

    BIOLASE, Inc. is in the Medical Devices industry

    What country is BIOLASE, Inc. based in?

    BIOLASE, Inc. is headquartered in United States

    When did BIOLASE, Inc. go public?

    BIOLASE, Inc.'s initial public offering (IPO) was on November 12, 1992

    Is BIOLASE, Inc. in the S&P 500?

    No, BIOLASE, Inc. is not included in the S&P 500 index

    Is BIOLASE, Inc. in the NASDAQ 100?

    No, BIOLASE, Inc. is not included in the NASDAQ 100 index

    Is BIOLASE, Inc. in the Dow Jones?

    No, BIOLASE, Inc. is not included in the Dow Jones index

    When was BIOLASE, Inc.'s last earnings report?

    BIOLASE, Inc.'s most recent earnings report was on November 8, 2024

    When does BIOLASE, Inc. report earnings?

    The date for BIOLASE, Inc.'s next earnings report has not been announced yet
    On this page